Matching medicines with microorganisms
Antimicrobials include antibacterial, antiviral, antifungal and antiparasitic medicines. Bacterial antibiotic resistance is one category; the patient’s body is not becoming immune to a drug. Describing resistance requires specifying the microorganism, medicine and testing conditions before results from different settings can be meaningfully compared.
Changes and defence mechanisms
Genetic changes can alter drug targets, reduce entry or enable mechanisms that inactivate a medicine. Resistance-related genes can also move between microorganisms. Exposure changes relative opportunities for survival and multiplication, allowing both existing resistant variants and newly arising changes to spread under particular conditions.
References: [2]
Transmission beyond one exposure
Resistant microorganisms spread through contacts, health-care environments and other routes, with animals, agriculture and environmental settings forming connected networks. Someone without prior exposure to a particular drug can encounter an already resistant organism. Public-health investigation therefore examines both medicine use and transmission, linking laboratory findings with actual conditions of contact and care.
Surveillance, prevention and access
Surveillance tracks patterns, infection prevention limits spread, and research and reliable access influence appropriate treatment. Both unsuitable exposure and lack of appropriate medicines contribute to problems. Sustained cooperation across sectors is needed; numbers of new products or total consumption alone provide incomplete descriptions of the system’s performance.
References: [1]